IO Biotech Inc Cash Flow-to-Debt Ratio
IO Biotech Inc cash flow-to-debt ratio. IO Biotech Inc (IOBT) has a Cash Flow-to-Debt Ratio of -0.47x as of September 2025, meaning its operating cash flow of $-18.48 Million could theoretically repay 0% of its total liabilities ($39.05 Million) in one year. See IO Biotech Inc (IOBT) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of IO Biotech Inc (2019–2024)
Cash flow-to-debt ratio of IO Biotech Inc from 2019 to 2024. Historical debt coverage capacity for IO Biotech Inc across 6 annual periods. Also explore IO Biotech Inc net asset momentum to track the company's year-over-year net asset growth rate.
IO Biotech Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
IO Biotech Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for IO Biotech Inc. For the full cash flow conversion analysis, see IO Biotech Inc (IOBT) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.98x | $-82.35 Million | $20.68 Million | ▲ +2.6% |
| 2023 | -4.09x | $-71.74 Million | $17.56 Million | ▲ +11.4% |
| 2022 | -4.61x | $-59.73 Million | $12.95 Million | ▼ -17.6% |
| 2021 | -3.92x | $-40.65 Million | $10.36 Million | ▼ -20.1% |
| 2020 | -3.26x | $-9.96 Million | $3.05 Million | ▼ -300.0% |
| 2019 | -0.82x | $-8.89 Million | $10.89 Million | — |